Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · operational-macro

BD to Expand Domestic Medical Supply Manufacturing

14 October 2026 · By · Wire by Fusion42

Published

14 October 2026

Topic

operational-macro

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at respiratory-therapy.com →

◆ Verified

Fusion42 · 14 October 2026 · Fusion42 review

BD has secured a $19 billion partnership with the US government to expand domestic manufacturing capacity for essential medical consumables and improve supply chain resilience, including tariff relief under Section 232.

This Wire brief sits within Fusion42's coverage of Medtech, and 5 sources have reported it between 6 Oct 2026 and 14 Oct 2026.

◆ ◆ The Wire takeaway

The US government’s $19bn deal to boost BD’s domestic medical supply manufacturing opens a larger, more secure market for local producers. You now have a chance to partner with BD or expand your US operations ahead of rising domestic demand and tariff protections.

◆ Coverage

5 sources · first reported 6 Oct 2026 · latest 14 Oct 2026

◆ Related on Wire

◆ Topics

Medtechmedical-suppliesmanufacturing-expansionsupply-chain-securitytariff-reliefus-governmentbd